Training marks Poland's first International Psychedelic Therapy Training Program, expanding MAPS' global education initiativeProgram demonstrates ...
PharmAla Biotech Holdings Inc. (“PharmAla ” or the “Company ”) (CSE: MDMA) (OTCQB:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel ...
PharmAla’s LaNeo™ MDMA – already in use in Clinical Trials worldwide, and in commercial medical use in a growing number of countries – is now imported, released, and ready for use in the continental ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback